Where
Zoom link to be sent2021-22 Graft versus Host Disease
Virtual Symposium Series - Part III
ABOUT THE GvHD NATIONAL SYMPOSIUM
This unique conference focuses on cutting edge research and new treatments. Our symposia have two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.
The Meredith A. Cowden Foundation in collaboration with the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute, created the GvHD National Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment.
Over 1,700 people have attended our events, which have provided an opportunity for attendees to interact with some of the world’s leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients. Our past symposiums have served as invaluable experiences to learn, network and exchange ideas with each other.
Due to COVID19 restrictions, our in person meeting has been postponed to 2022. To support those with chronic graft versus host disease and those in the community, we continue our virtual symposia series with our third installment:
Friday, January 28th, 2022 at 10AM – 12PM EST
Dr. Betty Hamilton, MD
Cleveland Clinic
“Late Effects and Survivorship after Hematopoietic Cell Transplantation”
*Presentation followed by a patient-centered Q&A panel hosted by the GvHD planning committee.
We hope that you will join us for this exciting virtual event!
Thank you to our sponsors!
